METHOTREXATE SUBCUTANEOUS

Accord Healthcare Inc🇨🇦 Health Canada

Approval Id: 29390249d23140b5
Drug Approval Canada Name: METHOTREXATE SUBCUTANEOUS
Product Name: METHOTREXATE SUBCUTANEOUS
Status: Marketed
Status Date: 2020-02-28
Original Market Date: 2020-02-28
Din: 02491346
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L04AX03 METHOTREXATE
Atc Name: l 04 ax 03
Aig Number: 0107545005
Company Name: Accord Healthcare Inc
Company Address: 3535 Boulevard St-Charles, Suite 704, Kirkland, Quebec, Canada, H9H 5B9
Company Detail Path: /organization/accord-healthcare-inc

METHOTREXATE (METHOTREXATE SODIUM)

20 MG / 0.4 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

29390249d23140b5

Type

Standard